Marc Isaac Damelin
2002 PhD Graduate in Biophysics
Chief Scientific Officer at Alphina Therapeutics
Dissertation Title: Analysis of Nuclear Organization: Nucleocytoplasmic Transport and Chromatin Remodeling
PhD Dissertation Advisor: Dr. Pamela A. Silver, Dept. of Biological Chemistry & Molecular Pharmacology, Dana-Farber Cancer Institute/ Harvard Medical School
Marc has been in the biopharma industry since 2007, following a postdoctoral fellowship with the Damon Runyon Cancer Research Foundation. His industry work has focused on developing antibody-drug conjugates (ADC) for oncology, with experience in big pharma as well as biotech.